vs
Side-by-side financial comparison of MODIV INDUSTRIAL, INC. (MDV) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Entrada Therapeutics, Inc. is the larger business by last-quarter revenue ($20.6M vs $11.1M, roughly 1.9× MODIV INDUSTRIAL, INC.). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -84.4%, a 95.3% gap on every dollar of revenue. On growth, MODIV INDUSTRIAL, INC. posted the faster year-over-year revenue change (-5.6% vs -65.2%). Over the past eight quarters, Entrada Therapeutics, Inc.'s revenue compounded faster (6.4% CAGR vs -3.8%).
MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
MDV vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.1M | $20.6M |
| Net Profit | $1.2M | $-17.3M |
| Gross Margin | — | — |
| Operating Margin | 45.8% | -106.0% |
| Net Margin | 11.0% | -84.4% |
| Revenue YoY | -5.6% | -65.2% |
| Net Profit YoY | -22.0% | -173.8% |
| EPS (diluted) | $0.02 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.1M | — | ||
| Q3 25 | $11.7M | — | ||
| Q2 25 | $11.8M | — | ||
| Q1 25 | $11.8M | $20.6M | ||
| Q4 24 | $11.7M | $37.4M | ||
| Q3 24 | $11.7M | $19.6M | ||
| Q2 24 | $11.4M | $94.7M | ||
| Q1 24 | $12.0M | $59.1M |
| Q4 25 | $1.2M | — | ||
| Q3 25 | $1.0M | — | ||
| Q2 25 | $-2.0M | — | ||
| Q1 25 | $829.0K | $-17.3M | ||
| Q4 24 | $1.6M | $1.1M | ||
| Q3 24 | $-587.0K | $-14.0M | ||
| Q2 24 | $1.3M | $55.0M | ||
| Q1 24 | $3.7M | $23.5M |
| Q4 25 | 45.8% | — | ||
| Q3 25 | 41.4% | — | ||
| Q2 25 | 9.8% | — | ||
| Q1 25 | 40.2% | -106.0% | ||
| Q4 24 | 45.4% | -15.7% | ||
| Q3 24 | 42.0% | -110.7% | ||
| Q2 24 | 44.6% | 56.4% | ||
| Q1 24 | 55.6% | 35.7% |
| Q4 25 | 11.0% | — | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | -17.1% | — | ||
| Q1 25 | 7.0% | -84.4% | ||
| Q4 24 | 13.3% | 3.0% | ||
| Q3 24 | -5.0% | -71.7% | ||
| Q2 24 | 11.6% | 58.1% | ||
| Q1 24 | 31.1% | 39.7% |
| Q4 25 | $0.02 | — | ||
| Q3 25 | $0.00 | — | ||
| Q2 25 | $-0.32 | — | ||
| Q1 25 | $-0.01 | $-0.42 | ||
| Q4 24 | $0.07 | $-0.20 | ||
| Q3 24 | $-0.18 | $-0.35 | ||
| Q2 24 | $0.03 | $1.55 | ||
| Q1 24 | $0.33 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.4M | $67.8M |
| Total DebtLower is stronger | $261.5M | — |
| Stockholders' EquityBook value | $162.7M | $417.3M |
| Total Assets | $476.5M | $486.5M |
| Debt / EquityLower = less leverage | 1.61× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | — | ||
| Q3 25 | $8.3M | — | ||
| Q2 25 | $5.8M | — | ||
| Q1 25 | $6.2M | $67.8M | ||
| Q4 24 | $11.5M | $101.2M | ||
| Q3 24 | $6.8M | $78.0M | ||
| Q2 24 | $18.9M | $185.3M | ||
| Q1 24 | $18.4M | $68.4M |
| Q4 25 | $261.5M | — | ||
| Q3 25 | $279.7M | — | ||
| Q2 25 | $279.7M | — | ||
| Q1 25 | $279.7M | — | ||
| Q4 24 | $279.8M | — | ||
| Q3 24 | $279.7M | — | ||
| Q2 24 | $279.7M | — | ||
| Q1 24 | $279.6M | — |
| Q4 25 | $162.7M | — | ||
| Q3 25 | $164.8M | — | ||
| Q2 25 | $165.6M | — | ||
| Q1 25 | $171.1M | $417.3M | ||
| Q4 24 | $190.1M | $428.7M | ||
| Q3 24 | $186.3M | $422.4M | ||
| Q2 24 | $187.0M | $429.9M | ||
| Q1 24 | $188.0M | $269.4M |
| Q4 25 | $476.5M | — | ||
| Q3 25 | $499.6M | — | ||
| Q2 25 | $498.9M | — | ||
| Q1 25 | $506.8M | $486.5M | ||
| Q4 24 | $507.8M | $526.3M | ||
| Q3 24 | $507.4M | $554.6M | ||
| Q2 24 | $519.5M | $582.0M | ||
| Q1 24 | $522.5M | $510.8M |
| Q4 25 | 1.61× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 1.50× | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 1.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.0M | $-38.5M |
| Free Cash FlowOCF − Capex | — | $-39.7M |
| FCF MarginFCF / Revenue | — | -192.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 12.34× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.0M | — | ||
| Q3 25 | $4.1M | — | ||
| Q2 25 | $3.9M | — | ||
| Q1 25 | $3.0M | $-38.5M | ||
| Q4 24 | $18.2M | $-31.6M | ||
| Q3 24 | $5.1M | $-24.3M | ||
| Q2 24 | $4.7M | $39.8M | ||
| Q1 24 | $3.0M | $-25.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-39.7M | ||
| Q4 24 | — | $-32.2M | ||
| Q3 24 | — | $-24.9M | ||
| Q2 24 | — | $38.8M | ||
| Q1 24 | — | $-26.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -192.9% | ||
| Q4 24 | — | -86.2% | ||
| Q3 24 | — | -127.3% | ||
| Q2 24 | — | 41.0% | ||
| Q1 24 | — | -44.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.6% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | 12.34× | — | ||
| Q3 25 | 3.95× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.68× | — | ||
| Q4 24 | 11.72× | -27.94× | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.55× | 0.72× | ||
| Q1 24 | 0.80× | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
